ラムス・インターミディアスの関連は,左側主幹幹の動脈硬化性プラークの増加と関連している
Leili Pourafkari1, Salman Ansari2, April Kinninger1
1Department of Medicine, Lundquist Institute at Harbor-UCLA Medical Center, Los Angeles, CA, USA.
The international journal of cardiovascular imaging
|February 18, 2026
まとめ
Ramus intermedius (RI) 変異の血管は,左側主動脈 (LM) の動脈硬化プラークの増加と狭窄に関連しています. この発見は,冠動脈疾患の進行のための潜在的なリスク要因を強調しています.
科学分野:
- 心血管画像検査についてです.
- 介入性心臓病学 介入性心臓病学
- アナトミック・バリエーション
背景:
- ラムス・インターミディアス (Ramus intermedius,RI) は,左側主動脈 (LM) の冠動脈の分岐に起因する解剖学的変異体である.
- LMにおける冠動脈血流動の動態と動脈硬化性プラークの形成に影響を与える RIの潜在的な役割は完全に理解されていません.
- RIのような解剖学的変異を理解することは,心血管リスクの評価に不可欠です.
研究 の 目的:
- ラムス・インターミディアス (RI) の存在と,左側主動脈 (LM) の動脈硬化性プラークと狭窄との関連を調査する.
- RIがLM動脈硬化症の独立した危険因子であるかどうかを判断する.
主な方法:
- コンピュータトモグラフィー・アニオグラフィー (CTA) を受けた11,497人の被験者の遡及的分析.
- RIの存在の専門家の評価とLMプラークの負担と狭窄の評価.
- 二変数および多変数ロジスティック回帰分析,従来の心血管疾患リスク因子に調整.
主要な成果:
- ラムス・インターミディアス (RI) は,研究集団の11%に存在していました.
- RIを持つ被験者は,プラークの負担 (41%対26%) と,LMの狭窄のどの程度も,それ以外の被験者と比較して,有意に高い罹患率を示しました.
- RIの存在は,心臓血管リスク因子 (OR 1.71 [1.51-1.95]) を調整した後も,LMプラークと有意に関連していた.
結論:
- 解剖学的変異体Ramus intermedius (RI) は,動脈硬化性プラークの有意な増加と,左側主動脈 (LM) の狭窄のより高い程度と関連しています.
- RIは,LM幹における動脈硬化症の発生に寄与する独立した危険因子である可能性があります.
- この関連性とその臨床的影響の背後にあるメカニズムを明らかにするために,さらなる研究が必要である.
関連する概念動画
Atherosclerosis I: Introduction
1.5K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.5K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
590
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
590
Peripheral Artery Disease I: Introduction
426
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
426
The Arch of Aorta
2.0K
The coronary arteries, originating from the ascending aorta, bifurcate from two sinuses located within the ascending aorta. Positioned just above the aortic semilunar valve, these sinuses house essential aortic baroreceptors and chemoreceptors, crucial for maintaining cardiac function. The left coronary artery and the right coronary artery branch off from the left posterior and anterior aortic sinuses, respectively.
Encircling the heart, the coronary arteries form a ring-like structure before...
Encircling the heart, the coronary arteries form a ring-like structure before...
2.0K
Atherosclerosis III: Management
465
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
465
Coronary Artery Disease II: Pathophysiology
646
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
646


